MICHELE GUNNING: Open Payments
NPI 1144421132 · PETERBOROUGH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 96 payments from 16 companies in 2025. Trend: 2023 $1,486 · 2024 $2,139 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $678 |
| Vanda Pharmaceuticals Inc. | 10 | $259 |
| Neurocrine BioSciences, Inc. | 7 | $150 |
| Lundbeck LLC | 10 | $150 |
| Alkermes, Inc. | 3 | $147 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $136 |
| Collegium Pharmaceutical, Inc. | 7 | $119 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Orexo US, Inc. | 3 | $59 |
Products named: VRAYLAR, FANAPT, REXULTI, INGREZZA, CAPLYTA, LYBALVI, Jornay PM, Auvelity.
Industry payments across NH — which companies pay providers there.
